Transcriptome profiling in response to adiponectin in human cancer-derived cells

Area of Science:

• Endocrinology
• Molecular Biology
• Oncology

Background:

• Adiponectin, an adipocyte-derived hormone, exhibits protective effects in various conditions, including cancer.
• Growing evidence suggests adiponectin's potential as an anticancer agent, but its precise mechanisms in cancer cells remain largely unknown.

Purpose of the Study:

• To elucidate the molecular mechanisms underlying adiponectin's anticancer effects by identifying genes modulated by adiponectin in cancer cells.
• To explore the signaling pathways and transcription factors involved in adiponectin-mediated gene expression changes in malignant neoplasms.

Main Methods:

• Utilized microarray analysis to identify genes modulated by full-length recombinant human adiponectin in three cancer cell lines.
• Employed functional enrichment tests and text mining of PubMed data to analyze gene functions and disease associations.
• Conducted bioinformatic analysis to predict signaling pathways and transcription factors mediating adiponectin's effects.

Main Results:

• Identified 1,301 genes commonly modulated by adiponectin stimulation across three cancer cell lines.
• Found that modulated genes are primarily involved in translation regulation, immune/stress responses, and cell proliferation.
• Bioinformatic analysis revealed diverse signaling pathways and transcription factors potentially involved in adiponectin's action, highlighting the complexity of its effects.

Conclusions:

• Adiponectin significantly impacts gene expression in cancer cells, affecting key cellular processes.
• The study supports a link between adiponectin and cancer mechanisms, with a substantial proportion of affected genes related to malignant neoplasms.
• Understanding these complex molecular mechanisms is crucial for developing adiponectin-based cancer therapies.